Vaccins à ARN messager contre le Covid-19 : piqûre de rappel [mRNA Covid vaccines: What do we know eight months after deployment]
Fiche du document
10 novembre 2021
- doi: 10.53738/REVMED.2021.17.758.1910
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.758.1910
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34755939
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_CE2F5557994E9
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Communicable diseases--Vaccination Preventive inoculation Inoculation Preventive inoculation Diseases--VaccinationCiter ce document
A. Miauton et al., « Vaccins à ARN messager contre le Covid-19 : piqûre de rappel [mRNA Covid vaccines: What do we know eight months after deployment] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.758.1910
Métriques
Partage / Export
Résumé
This paper summarizes the main knowledge on mRNA vaccines in September 2021. The only contraindication for a 1st dose of vaccine is an allergy to one of the components of the vaccine, but a specialized consultation is possible for an eventual split vaccination under medical supervision. Serious side effects are rare and consist mainly of myocarditis, shingles and appendicitis, but the risk/benefit ratio is always favorable for vaccination. Efficacy against severe COVID-19 is > 90 % after 6 months, and this against all variants. It is recommended to vaccinate pregnant women. A 3rd dose is not recommended at this time, except for immunosuppressed individuals without detectable antibodies after 2 doses. Vaccine mixing is possible, including with a viral vector vaccine.